Industry Collaboration

Dr. Mirzadeh looking into microscope

Join us in finding a cure for brain cancer

The Ivy Center’s experience with industry collaborators for early-phase clinical trials ranges from smaller, privately-held companies to multinational corporations. Our multidisciplinary team is expert in both pre-clinical and clinical drug development for brain tumors, providing cutting-edge solutions to common challenges facing drug discovery and development. We understand the market for this patient population and can help identify promising agents in your drug pipeline.

  • Minimal Upfront Investment: We pay for all trial costs, except for the drug
  • Limited Clinical Risk: Limited-dosing regimen in Phase 0 studies
  • Industry-friendly IP Policy: We make no demands on IP, data, or downstream revenue, other than the right to publish
  • Speed: Rapid accrual and efficient trial design; most trials open and close within 6 months
  • Expertise: No one has more experience with brain tumor Phase 0 studies

Industry Collaborators

bridgebio logo
Salarius logo
QED logo


If you represent a biotech or pharmaceutical company with investigational agents that would like to explore a partnership with the Ivy Brain Tumor Center please contact Dr. Nader Sanai.

Female lab tech working on a project

Five Scientific Cores

Gloved hands placing specimens in a container

CLIA Certified and CAP Accredited Labs